All Articles

"What I remember clearly is that I was supposed to have only 14 to 18 months to live. That was about 6 years ago," says Melanie Kabo. Read More ›

Here is an overview of vital things to consider after being diagnosed with multiple myeloma, from selecting your treatment team to understanding your insurance plan and costs. Read More ›

Enter immunotherapy, stage left. This bright star has gained some traction over the past 2 decades, with the promise of more effective and less hazardous ways to combat cancer. Read More ›

“Hands Off” emerged as my way of saying, “Let women make their own decisions about their bodies and healthcare.” Read More ›

March is Colorectal Cancer Awareness Month! Flip through this slideshow featuring the top risk factors for colorectal cancer, symptoms to look out for, and more. Conquer cancer with knowledge. Read More ›

In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease. Read More ›

Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts. Read More ›

Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab. Read More ›

Patients under age 40 with breast cancer who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received less invasive sentinel lymph node biopsies. Read More ›

According to the results of 2 recent analyses, dose-dense or dose-intense chemotherapy reduces the risk for breast cancer recurrence and improves survival compared with standard chemotherapy regimens. Read More ›